CVS Health Corporation (CVS)
CVS Health Corporation (CVS) Bernstein's 40th Annual Strategic Decisions Conference
CVS Health Corporation (NYSE:CVS ) Bernstein's 40th Annual Strategic Decisions Conference May 29, 2024 10:00 AM ET Company Participants Karen Lynch - President and CEO Tom Cowhey - Executive Vice President and Chief Financial Officer Conference Call Participants Lance Wilkes - Bernstein Lance Wilkes Okay. So we're going to kick-off.
How Are CVS Health's Profit Margins Trending?
CVS Health (NYSE: CVS) saw its net income expand by $4.2 billion or 101% y-o-y to $8.3 billion in 2023. This can primarily be attributed to the opioid litigation charges included in the 2022 results.
2 Beaten-Down Dividend Stocks to Buy and Hold For 10 Years
CVS Health provides a comprehensive suite of interrelated healthcare services. Gilead Sciences' sales are growing steadily, and newer approvals should help.
CVS Health: Downside Movement Is Overdramatic
CVS Health Corp's share price has fallen, presenting an attractive entry opportunity with a current dividend yield of 4.8%. The risk profile includes slashed guidance and increased costs, but these issues are not unique to CVS and may be temporary. CVS has shown consistent dividend growth over time and has a potential upside of 28.5% based on average Wall St. price targets.
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in CVS Stock.
CVS has long been a reliable dividend payer. Despite management's recent guidance cut, it still has room to raise its dividend.
Two CVS retail stores in Rhode Island join new national pharmacy union
Pharmacy staff at two CVS retail stores in Rhode Island voted to join a new national pharmacy union called The Pharmacy Guild. The results signal growing momentum in a movement to help thousands of U.S. pharmacy workers address what they call unsafe working conditions.
Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
CVS seeks investor to fund growth at Oak Street Health, Bloomberg reports
CVS Health Corp has been seeking a private equity partner to fund growth at Oak Street Health, a primary care provider it bought a year ago, Bloomberg News reported on Thursday.
CVS Health Enters Oversold Territory
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. CVS Health presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.
CVS shares lift as it welcomes CMA vet probe extension
CVS Group (AIM:CVSG), the veterinary firm, saw its shares bounce 3% higher on Thursday after it openly welcomed the commencement of an 18-month-long investigation into the industry. Britain's Competition and Markets Authority revealed it would be expanding its investigation into the vet industry, having created a new team of independent experts to oversee the research.
CVS Health (CVS) Expands Food and Beverage Line With New Launch
CVS Health's (CVS) Well Market brand offers a blend of mouthwatering flavors and nutritious options, expertly crafted and taste-tested by food enthusiasts.
CVS Health Stock Has a Silver Lining Called Value
Integrated healthcare retailer and insurer CVS Health Co. (NYSE: CVS) stock presents a value not seen in years. The medical sector giant saw its shares punished on its Q1 2024 top and bottom line miss, as well as lowered full-year 2024 guidance.
